Zurcher Kantonalbank Zurich Cantonalbank lowered its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 31.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 48,391 shares of the company's stock after selling 21,728 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Option Care Health were worth $1,123,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. Quarry LP boosted its holdings in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after purchasing an additional 2,628 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Option Care Health by 16.9% during the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after purchasing an additional 681 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in shares of Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after purchasing an additional 4,561 shares during the last quarter. Finally, KBC Group NV boosted its holdings in shares of Option Care Health by 16.2% during the 3rd quarter. KBC Group NV now owns 5,013 shares of the company's stock valued at $157,000 after purchasing an additional 700 shares during the last quarter. Institutional investors own 98.05% of the company's stock.
Analyst Ratings Changes
Several analysts have recently issued reports on the stock. Barrington Research upped their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a "neutral" rating and a $26.00 target price on the stock. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.
Check Out Our Latest Stock Report on OPCH
Insider Transactions at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.64% of the company's stock.
Option Care Health Trading Up 0.8 %
Shares of NASDAQ:OPCH traded up $0.29 during trading on Friday, reaching $34.58. 2,990,558 shares of the company were exchanged, compared to its average volume of 1,639,802. The firm has a market capitalization of $5.72 billion, a PE ratio of 29.06, a P/E/G ratio of 2.30 and a beta of 1.33. The business's fifty day simple moving average is $31.84 and its 200-day simple moving average is $28.32. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.85. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
